[Methods of ovulation induction].
Basing on the mechanism of the endocrine regulation of the reproductive events in the women causes and therapy of the endocrine sterility are discussed. Causes of endocrine sterility are divided into the entities hyperprolactinemic, hyperandrogenemic, hypo- and dysgonadotropic hypogonadism. Concerning these disturbances the specific therapeutic opportunities with the inhibitor of the prolactin secretion, with antiandrogenes, corticosteroids, antiestrogens, gonadotropins or gonadotropin-releasing hormone, respectively, are summarized. With a proposed scheme for diagnostic and therapeutic use an effective and economic proceeding in the treatment of the endocrine caused female sterility is intended.
D000726:Androgen Antagonists / Q000627:therapeutic use; D000728:Androgens / Q000097:blood; D001971:Bromocriptine / Q000627:therapeutic use; D002996:Clomiphene; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D012739:Gonadal Steroid Hormones / Q000097:blood; D006062:Gonadotropins / Q000627:therapeutic use; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy; D007247:Infertility, Female / Q000097:blood / Q000188:drug therapy*; D008090:Lisuride / Q000627:therapeutic use; D008711:Metergoline / Q000627:therapeutic use; D010060:Ovulation / Q000187:drug effects; D010062:Ovulation Induction / Q000379:methods*; D011239:Prednisolone / Q000627:therapeutic use; D011388:Prolactin / Q000097:blood
D000726:Androgen Antagonists; D000728:Androgens; D004965:Estrogen Antagonists; D012739:Gonadal Steroid Hormones; D006062:Gonadotropins; D008711:Metergoline; D002996:Clomiphene; D001971:Bromocriptine; D011388:Prolactin; D011239:Prednisolone; D008090:Lisuride
Methoden der Ovulationsinduktion.